![Toujeo 300 units/ml SoloStar, solution for injection in a pre-filled pen - Summary of Product Characteristics (SmPC) - (emc) Toujeo 300 units/ml SoloStar, solution for injection in a pre-filled pen - Summary of Product Characteristics (SmPC) - (emc)](https://www.medicines.org.uk/emc/images/spc/spc~30586~12~image1.png)
Toujeo 300 units/ml SoloStar, solution for injection in a pre-filled pen - Summary of Product Characteristics (SmPC) - (emc)
![New Diabetes Therapies: Practical Considerations for Outpatient Use Sarah L. Anderson, PharmD, BCPS CPS 2016 Winter Seminar January 13, ppt download New Diabetes Therapies: Practical Considerations for Outpatient Use Sarah L. Anderson, PharmD, BCPS CPS 2016 Winter Seminar January 13, ppt download](https://images.slideplayer.com/29/9496250/slides/slide_31.jpg)
New Diabetes Therapies: Practical Considerations for Outpatient Use Sarah L. Anderson, PharmD, BCPS CPS 2016 Winter Seminar January 13, ppt download
![Calling the Shots” Case Studies in Adding Insulin and Non-insulin Injectables Cathy Donahue Smith, APRN, CDE Christiana Care Endocrinology. - ppt download Calling the Shots” Case Studies in Adding Insulin and Non-insulin Injectables Cathy Donahue Smith, APRN, CDE Christiana Care Endocrinology. - ppt download](https://slideplayer.com/11958980/68/images/slide_32.jpg)
Calling the Shots” Case Studies in Adding Insulin and Non-insulin Injectables Cathy Donahue Smith, APRN, CDE Christiana Care Endocrinology. - ppt download
![Conversion from insulin glargine U-100 to insulin glargine U-300 or insulin degludec and the impact on dosage requirements - Scott M. Pearson, Jennifer M. Trujillo, 2018 Conversion from insulin glargine U-100 to insulin glargine U-300 or insulin degludec and the impact on dosage requirements - Scott M. Pearson, Jennifer M. Trujillo, 2018](https://journals.sagepub.com/cms/10.1177/2042018818760962/asset/images/large/10.1177_2042018818760962-fig1.jpeg)